Page last updated: 2024-10-23

bunazosin and Acute Disease

bunazosin has been researched along with Acute Disease in 2 studies

bunazosin: structure

Acute Disease: Disease having a short and relatively severe course.

Research Excerpts

ExcerptRelevanceReference
"Carvedilol, a nonselective beta-blocker with additional alpha1-adrenergic blocking and antioxidant properties, has been shown to be cardioprotective in experimental myocarditis."7.74Protective effects of carvedilol in murine model with the coxsackievirus B3-induced viral myocarditis. ( Ji-Fei, T; Jia-Feng, L; Jiang-Hua, R; Li-Sha, G; Peng, C; Peng-Lin, Y; Yue-Chun, L; Zhan-Qiu, Y, 2008)
"Carvedilol, a nonselective beta-blocker with additional alpha1-adrenergic blocking and antioxidant properties, has been shown to be cardioprotective in experimental myocarditis."3.74Protective effects of carvedilol in murine model with the coxsackievirus B3-induced viral myocarditis. ( Ji-Fei, T; Jia-Feng, L; Jiang-Hua, R; Li-Sha, G; Peng, C; Peng-Lin, Y; Yue-Chun, L; Zhan-Qiu, Y, 2008)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yue-Chun, L1
Li-Sha, G1
Jiang-Hua, R1
Peng-Lin, Y1
Jia-Feng, L1
Ji-Fei, T1
Peng, C1
Zhan-Qiu, Y1
Okazaki, Y1
Mishima, M1
Hirayama, A1
Komamura, K1
Asada, S1
Ohara, T1
Lee, JM1
Matsumura, Y1
Yamamoto, K1
Nishida, K1

Other Studies

2 other studies available for bunazosin and Acute Disease

ArticleYear
Protective effects of carvedilol in murine model with the coxsackievirus B3-induced viral myocarditis.
    Journal of cardiovascular pharmacology, 2008, Volume: 51, Issue:1

    Topics: Acute Disease; Adrenergic beta-Antagonists; Animals; Anti-Inflammatory Agents; Antioxidants; Carbazo

2008
[Acute effects of oral bunazosin-hydrochloride in acute heart failure].
    Kokyu to junkan. Respiration & circulation, 1989, Volume: 37, Issue:11

    Topics: Acute Disease; Administration, Oral; Adrenergic alpha-Antagonists; Aged; Female; Heart Failure; Hemo

1989